z-logo
open-access-imgOpen Access
Risk stratification of colorectal polyps for predicting residual or recurring adenoma using the Size/Morphology/Site/Access score
Author(s) -
Barosa Rita,
Mohammed Noor,
Rembacken Bjorn
Publication year - 2018
Publication title -
ueg journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.667
H-Index - 35
eISSN - 2050-6414
pISSN - 2050-6406
DOI - 10.1177/2050640617742485
Subject(s) - medicine , risk stratification , adenoma , colorectal cancer , colorectal adenoma , colorectal polyp , stratification (seeds) , residual , general surgery , colonoscopy , cancer , seed dormancy , botany , germination , algorithm , dormancy , computer science , biology
Background and Aims Endoscopic mucosal resection is an effective and safe procedure to manage large non‐pedunculated colonic polyps for which residual/recurrent adenoma is the main drawback. Size/Morphology/Site/Access score determines polypectomy difficulty. We aimed to describe residual/recurrent adenoma rate according to Size/Morphology/Site/Access and to select the ize/Morphology/Site/Access cut‐off to predict low residual/recurrent adenoma. Methods This was a retrospective cohort study of endoscopic mucosal resection for large non‐pedunculated colonic polyps performed in a tertiary centre. Results Three hundred and sixteen procedures were included. The mean size of lesions was 34.5 ± 17.1 mm, 59.5% were sessile, 60.4% were in the right colon and in 17.7% ( n  = 56) the access was difficult. Of the lesions, 83.6% were Size/Morphology/Site/Access 3–4. Residual/recurrent adenoma at first and second follow‐up was significantly lower in Size/Morphology/Site/Access 2 (1.9% and 0.0%, respectively) when compared to Size/Morphology/Site/Access 3 (18.2%, p  = 0.004 and 6.7%, p  = 0.049) and Size/Morphology/Site/Access 4 (30.8%, p  < 0.001 and 22.7%, p  = 0.030). The negative predictive value of Size/Morphology/Site/Access 2 for residual/recurrent adenoma at second follow‐up was 86.1%. On multivariate analyses, Size/Morphology/Site/Access 3–4 predicted residual/recurrent adenoma at first (odds ratio 11.96, 95% confidence interval 1.57–91.13) and second follow‐up (odds ratio 2.47, 95% confidence interval 1.51–4.22) and had higher cumulative incidence of residual/recurrent adenoma compared to Size/Morphology/Site/Access 2 ( p  ≤ 0.003). Conclusion Use of the Size/Morphology/Site/Access score allows cases to be identified with a low risk of residual/recurrent adenoma.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here